Lung Cancer News
Study Suggests Why Some Tobacco Smokers Don’t Get Lung Cancer
One of the major causes behind lung cancer remains smoking, yet only a minority of smokers develops this disease. A new study has been led by scientists at [...]
FDA Approves Nivolumab Plus Chemo as Neoadjuvant Therapy for NSCLC Treatment
The FDA has approved nivolumab plus platinum-doublet chemotherapy for patients with non-small cell lung cancer in the neoadjuvant setting. Nivolumab is the [...]
New Rapid Blood Test To Detect Early Stage Lung Cancer
In the arena of lung cancer, new researches and studies are being carried out all around the world to help the patients in its early detection and timely cure. [...]
Lung Cancer Screening in Non-Smoker Women in Taiwan Associated with Overdiagnosis
A new study based on data from a National Cancer Registry in Taiwan has found that lung cancer screening may lead to overdiagnosis at the population level. The [...]
NICE Approves Combination Therapy for Squamous Non-Small Cell Lung Cancer
There are mainly two different groups of lung cancer: non-small cell lung cancer and small cell lung cancer. These groups can further be split into more groups [...]
Study Finds Blood Tests to help Predict Lung Cancer Screenings
According to a new study published in the Journal of Clinical Oncology, a blood test along with a risk model based on person’s history can more accurately [...]
Study: Lung Cancer Screenings Associated with Death Decline
Lung cancer is one of the leading causes of cancer deaths in the United States and is diagnosed in more than 2lac people annually. According to a Mount Sinai [...]
Study Shows Treating Depression Could Lengthen Lung Cancer Survival
Depression is a common symptom that comes with patients suffering from lung cancer. During the journey from lung cancer diagnosis to its treatment, involves [...]
US FDA Approves Roche’s Tecentriq as Adjuvant Treatment for Early NSCLC
The US Food and Drug Administration (FDA) has approved Roche’s Tecentriq or atezolizumab as adjuvant treatment for patients with Stage II-IIIA non-small cell [...]
Takeda’s Exkivity Approved by FDA for Rare form of Lung Cancer
Takeda Pharmaceutical Co. Ltd. becomes the first one to get FDA approval for an oral drug targeted against rare form of non-small cell lung cancer. FDA has [...]
Indian Scientists Develop 3D Robotic Motion Phantom for Lung Cancer Treatment
Indian scientists have developed a novel three-dimensional robotic motion phantom that is capable of reproducing human lung motion. This robotic motion has [...]
Researchers Find Potential Marker for Success in Immunotherapy in Lung Cancer Patients
Lung Cancer has the highest mortality rate of all cancer and smoking remains the main cause behind this deadly disease. As far as the treatment options for [...]